West Pharmaceutical Services on LinkedIn: We are delighted to share th www.linkedin.com 查看3 条更新 总部 Exton, PA 公司盈利 13 亿至 68 亿(新元) 员工 10,000人以上 行业性质 醫療保健產品製造 查找另一家公司 搜索
EXTON, Pa.,Dec. 11, 2024/PRNewswire/ --West Pharmaceutical Services, Inc.(NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition ofMs. Haugen, W...
West Pharmaceutical Services, Inc. announced that it will release fourth-quarter and full-year 2022 financial results before the market opens on Thursday, February 16, 2023, and will follow with a conference call to discuss the results and busi...
West Pharmaceutical Services Inc的平均EV/EBIT(5年)排名为第40.7x名,处于板块内95.1%的水平。下表提供了更多数据的摘要: 板块医疗保健的平均EV/EBIT(5年) 经济风险区类别 发达 全部成分股 2,509 包括的成分股 2,409 分钟 -141.3x 最大值 128.2x 中位数 -3.6x 平均值 -1.7x 标准差 26.4x 用本选股器选...
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will release fourth-quarter and full-year 2021 financial results before the market opens on Thursday, February 17, 2022, and
West Pharmaceutical Services, Inc. announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance.
West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2023, updated full-year 2023 financial guidance and declared a fourth-quarter 2023 dividend.
Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic version of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries, Inc. Lupin receives U.S. FDA approval for Hydrocortisone Valerate Cream New product introductions in the last two years have been a main driver of Taro's growth...
Applications for chiral chromatography, demand for chiral columns, orders for bulk CSPs, and outsourcing services have also increased. Pharmaceutical companies, particularly those engaged in drug discovery, early-stage research, and chemical development, rely on chromatography to meet drug development ...
West Pharmaceutical Services, Inc. announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.